Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology
Authors:
- 9 May 2014
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 33 (10) , 1741-1747
Abstract
We aimed to determine the incidence of Clostridium difficile infection (CDI), the molecular epidemiology of circulating C. difficile strains and risk factors for CDI among hospitalised children in the Auckland region. A cross-sectional study was undertaken of hospitalised children C. difficile using a two-step testing algorithm including polymerase chain reaction (PCR). C. difficile was cultured and PCR ribotyping performed. Demographic data, illness characteristics and risk factors were compared between children with and without CDI. Non-duplicate stool specimens were collected from 320 children with a median age of 1.2 years (range 3 days to 15 years). Forty-six patients (14 %) tested met the definition for CDI. The overall incidence of CDI was 2.0 per 10,000 bed days. The percentage of positive tests among neonates was only 2.6 %. PCR ribotyping showed a range of strains, with ribotype 014 being the most common. Significant risk factors for CDI were treatment with proton pump inhibitors [risk ratio (RR) 1.74, 95 % confidence interval (CI) 1.09–5.59; p = 0.002], presence of underlying malignancy (RR 2.71, 95 % CI 1.65–4.62; p = 0.001), receiving chemotherapy (RR 2.70, 95 % CI 1.41–4.83; p = 0.003) and exposure to antibiotics (RR 1.17, 95 % CI 0.99–1.17; p = 0.03). C. difficile is an important cause of healthcare-associated diarrhoea in this paediatric population. The notion that neonatal populations will always have high rates of colonisation with C. difficile may not be correct. Several risk factors associated with CDI among adults were also found to be significant.Keywords
This publication has 38 references indexed in Scilit:
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionThe Lancet Infectious Diseases, 2013
- Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Molecular Epidemiology of Clostridium difficile Strains in Children Compared with That of Strains Circulating in Adults with Clostridium difficile-Associated InfectionJournal of Clinical Microbiology, 2011
- Clostridium difficile Infection and Treatment in the Pediatric Inflammatory Bowel Disease PopulationJournal of Pediatric Gastroenterology and Nutrition, 2011
- Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Clostridium difficileInfections among Hospitalized Children, United States, 1997–2006Emerging Infectious Diseases, 2010
- Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotypingJournal of Medical Microbiology, 2008
- Clostridium difficile-associated disease in children with solid tumorsSupportive Care in Cancer, 2008
- Clostridium difficile-Associated Diarrhea and ColitisMayo Clinic Proceedings, 2001
- Prospective study of toxigenic Clostridium difficile in children given amoxicillin/clavulanate for otitis mediaThe Pediatric Infectious Disease Journal, 1996